FilingReader Intelligence

Jafron Biomedical gains approval for new medical device

May 28, 2025 at 05:22 PM UTCBy FilingReader AI

Jafron Biomedical (SZSE:300529) announced it has received a medical device registration certificate from the Guangdong Provincial Drug Administration for its new product: a disposable waste fluid bag, effective May 27, 2025. Classified as a Class II medical device, the bag functions as a waste fluid collection device during hemodialysis and hemofiltration treatments. The registration is valid for five years, expiring on May 26, 2030. Jafron believes that integration of the bag with its existing equipment and tubing will strengthen its position in the blood purification field.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SZSE:300529Shenzhen Stock Exchange

News Alerts

Get instant email alerts when Jafron Biomedical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →